SEARCH

SEARCH BY CITATION

References

  • Aggeler, P.M., White, S.G., Glendening, M.B., Page, E.W., Leake, T.B. & Bates, G. (1952) Plasma thromboplastin component (PTC): a new disease resembling hemophilia. Proceedings of the Society for Experimental Biology and Medicine, 79, 692694.
  • Alexander, B., Goldstein, R., Landwehr, G. & Cook, C.D. (1951) Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. Journal of Clinical Investigation, 30, 596608.
  • Biggs, R. & Douglas, A.S. (1953) The thromboplastin generation test. Journal of Clinical Pathology, 6, 2329.
  • Biggs, R., Douglas, A.S., Macfarlane, R.G., Dacie, J.V., Pitney, W.R., Mersky, C. & O'Brien, J.R. (1952) Christmas disease: a condition previously mistaken for haemophilia. British Medical Journal, ii, 13781382.
  • De Nicola, P. (1961) Report of the sub-committee on new clotting factors. In: Progress in Coagulation. Transactions of the conference held under the auspices of the International Committee on Blood Clotting Factors, Wiesbaden, Germany, 3–6 September 1961 (ed. by I.S.Wright, F.Koller & E. Beck), p. 363. Friedrich-Karl Schattauer-Verlag, Stuttgart.
  • De Vries, A., Alexander, B. & Goldstein, R. (1949) A factor in serum which accelerates the conversion of prothrombin to thrombin. I. Its determination and some physiologic and biochemical properties. Blood, 4, 247258.
  • Denson, K.W. (1957) Electrophoretic studies of the Prower factor: a blood coagulation factor which differs from factor VII. British Journal of Haematology, 4, 313325.
  • Duckert, F., Jung, E. & Shmerling, D.H. (1961) A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombosis et Diathesis Haemorrhagica, 5, 170186.
  • Graham, J.B. (1988) ‘Stuart factor’ (coagulation factor X). A North Carolina saga. North Carolina Medical Journal, 49, 328331.
  • Graham, J.B., Barrow, E.M. & Hougie, C. (1957) Stuart clotting defect. II. Genetic aspects of a ‘new’ hemorrhagic defect. Journal of Clinical Investigation, 36, 497503.
  • Hathaway, W.E., Belhasen, L.P. & Hathaway, H.S. (1965) Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood, 26, 521532.
  • Hougie, C., Barrow, E.M. & Graham, J.B. (1957) Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called ‘stable factor’ (SPCA, proconvertin, factor VII). Journal of Clinical Investigation, 36, 485496.
  • Irsigler, K. (1963) Human brain tissue thromboplastin. The International Committee on Blood Clotting Factors: the past, present and future. In: Fibrinogen and Fibrin. Turnover of Clotting Factors. Transactions of the conference held under the auspices of the International Committee on Blood Clotting Factors, Gleneagles, Scotland, July 1963 (ed. by R.B.Hunter, F.Koller & E. Beck), p. 441. F. K. Schattauer-Verlag, Stuttgart.
  • Koller, F., Loeliger, A. & Duckert, F. (1951) Experiments on a new clotting factor (factor VII). Acta Haematologica, 6, 118.
  • Lee, C.A. & Rizza, C.R. (1998) Witnessing medical history: an interview with Rosemary Biggs. Haemophilia, 4, 769777.
  • Lewis, J.H., Fresh, J.W. & Ferguson, J.H. (1953) Congenital hypoproconvertinemia. Proceedings of the Society for Experimental Biology and Medicine, 84, 651654.
  • Macfarlane, R.G. (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature, 202, 498499.
  • Owen, Jr, C.A. (2001) A History of Blood Coagulation (ed. by W.L.Nichols & E.J.W.Bowie), Mayo Foundation for Medical Education & Research, Rochester.
  • Owen, Jr, C.A., Bowie, E.J.W. & Thompson, Jr, J.H. (1975) The Diagnosis of Bleeding Disorders, 2nd edn. Little Brown, Boston.
  • Owren, P.A. (1947) Parahaemophilia: a haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet, i, 446448.
  • Patek, A.J. & Taylor, F.H.L. (1937) Hemophilia. II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. Journal of Clinical Investigation, 16, 113124.
  • Pavlovsky, A. (1947) Contribution to the pathogenesis of hemophilia. Blood, 2, 185191.
  • Quick, A. (1943) On the constitution of prothrombin. American Journal of Physiology, 142, 212220.
  • Ratnoff, O.D. (1980) A quarter century with Mr. Hageman. Thrombosis and Haemostasis, 43, 9598.
  • Ratnoff, O.D. & Colopy, J.E. (1955) A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. Journal of Clinical Investigation, 34, 602613.
  • Ratnoff, O.D., Busse, R.J. & Sheon, R.P. (1968) The demise of John Hageman. New England Journal of Medicine, 279, 760761.
  • Robb-Smith, A.S. (1993) Life and Achievements of Professor Robert Gwyn Macfarlane FRS, pages 43–44. Royal Society of Medicine Services, London.
  • Rosenthal, L. (1954) Plasma thromboplastin antecedent (PTA) deficiency in man: clinical, coagulation, hereditary and therapeutic aspects. Journal of Clinical Investigation, 33, 961.
  • Rosenthal, R.L., Dreskin, O.H. & Rosenthal, N. (1953) New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proceedings of the Society for Experimental Biology and Medicine, 82, 171174.
  • Schmaier, A.H. (1997) Contact activation: a revision. Thrombosis and Haemostasis, 78, 101107.
  • Schulman, I. & Smith, C.H. (1952) Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood, 7, 794807.
  • Taylor, S.A.M., Duffin, J., Cameron, C., Teitel, J., Garvey, B. & Lillicrap, D.P. (1992) Characterization of the original Christmas disease mutation (cysteine 206serine): from clinical recognition to molecular pathogenesis. Thrombosis and Haemostasis, 67, 6365.
  • Telfer, T.P., Denson, K.W. & Wright, D.R. (1956) A ‘new’ coagulation defect. British Journal of Haematology, 2, 308316.
  • Waldman, R., Abraham, J.P., Rebuck, J.W., Caldwell, J., Saito, H. & Ratnoff, O.D. (1975) Fitzgerald factor: a hitherto unrecognised coagulation factor. Lancet, i, 949951.
  • Walsh, P.N. (2001) Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thrombosis and Haemostasis, 86, 7582.
  • Wiener, A.S. (1953) Christmas disease. British Medical Journal, i, 559560.
  • Wright, I.S. (1962) The nomenclature of blood clotting factors. Thrombosis et Diathesis Haemorrhagica, 7, 381388.
  • Wright, I.S. (1963) The International Committee on Blood Clotting Factors: the past, present and future. In: Fibrinogen and Fibrin. Turnover of Clotting Factors. Transactions of the conference held under the auspices of the International Committee on Blood Clotting Factors, Gleneagles, Scotland, July 1963 (ed. by R.B.Hunter, F.Koller & E. Beck), p. 1. F. K. Schattauer-Verlag, Stuggart.